Important notice

Labour dispute at Canada Post

We have put in place measures to mitigate the impact on our clients.

Gouvernement du Québec
Régie de l’assurance maladie

Important information

The contents of this webpage are in French only.

Find out whether a drug is covered

Over 8,000 prescription drugs are covered under the Public Prescription Drug Insurance Plan. They are included on a regularly updated list. Other drugs not on the list may also be covered on an exceptional basis.

Prescription drug search

Disclaimer : Search results do not have the same value as a legal document. To access the relevant legal document, please refer to the List of Medications.

4762 results found.

Example of search result explained

Hulio (syringe)

Exceptional medication
  • Active ingredient(s):
    adalimumab (ulcerative colitis-children)
  • Manufactured by:
    Biocon Biologics Canada Inc. (Biocon)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 50 mg/mL (0,4 mL) DIN : 99114162
    • Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 99114161

Hulio (pen)

Exceptional medication
  • Active ingredient(s):
    adalimumab (ulcerative colitis-children)
  • Manufactured by:
    Biocon Biologics Canada Inc. (Biocon)
  • Strength and dosage form:
    Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 99114163

Hulio (syringe)

Exceptional medication
  • Active ingredient(s):
    adalimumab (hidradenitis suppurativa)
  • Manufactured by:
    Biocon Biologics Canada Inc. (Biocon)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 50 mg/mL (0,4 mL) DIN : 99114041
    • Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 99114042

Hulio (pen)

Exceptional medication
  • Active ingredient(s):
    adalimumab (hidradenitis suppurativa)
  • Manufactured by:
    Biocon Biologics Canada Inc. (Biocon)
  • Strength and dosage form:
    Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 99114043

Hulio (syringe)

Exceptional medication
  • Active ingredient(s):
    adalimumab (uveitis)
  • Manufactured by:
    Biocon Biologics Canada Inc. (Biocon)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 50 mg/mL (0,4 mL) DIN : 99114104
    • Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 99114105

Hulio (pen)

Exceptional medication
  • Active ingredient(s):
    adalimumab (uveitis)
  • Manufactured by:
    Biocon Biologics Canada Inc. (Biocon)
  • Strength and dosage form:
    Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 99114106

Mylan-Amlopdipine/Atorvastatin

Covered
  • Active ingredient(s):
    amlodipine besylate/ atorvastatin calcium
  • Manufactured by:
    Mylan Pharmaceuticals ULC (Mylan)
  • Strength and dosage form:
    • Tablet 5 mg - 20 mg DIN : 2362767
    • Tablet 10 mg -10 mg DIN : 2362791
    • Tablet 5 mg - 40 mg DIN : 2362775
    • Tablet 10 mg - 20 mg DIN : 2362805
    • Tablet 5 mg - 80 mg DIN : 2362783
    • Tablet 10 mg - 40 mg DIN : 2362813
    • Tablet 10 mg - 80 mg DIN : 2362821
    • Tablet 5 mg -10 mg DIN : 2362759

Tenormin

Covered
  • Active ingredient(s):
    atenolol
  • Manufactured by:
    Searchlight Pharma Inc. (Search Phm)
  • Strength and dosage form:
    • Tablet 100 mg DIN : 2039540
    • Tablet 50 mg DIN : 2039532

Bimzelx

Exceptional medication
  • Active ingredient(s):
    bimekizumab (psoriatic arthritis and ankylosing spondylitis )
  • Manufactured by:
    U.C.B. Pharma Canada Inc. (U.C.B.)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution syringe 160 mg/mL (1 mL) DIN : 99114458
    • Subcutaneous Injectable Solution (pen) 160 mg/mL (1 mL) DIN : 99114459

Cefuroxime for injection USP

Covered
  • Active ingredient(s):
    cefuroxime (sodium)
  • Manufactured by:
    Hikma Canada Limited (Hikma)
  • Strength and dosage form:
    • Injection Powder 1.5 g DIN : 2422301
    • Injection Powder 750 mg DIN : 2422298
    • Injection Powder 7.5 g DIN : 2422328
Page 465 of 477

How did we do?

Was the information on this page useful to you?
Do not include any personal information. You will not receive any reply.